drugset / Trial / NCT05520112
Treatment of Recurrent Pregnancy Loss Using Mesenchymal Stem Cells
Phase 1/2
Unknown
20 enrolled
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus
Belarusian Medical Academy of Post-Graduate Education · collab
Non-randomizedParallel-groupOpen-labelTreatment
Summary
Treatment of Recurrent pregnancy loss using mesenchymal stem cells capable of differentiation in the endometrial-decidual direction.
Timeline
- Start
- 2022-11-01
- Primary completion
- 2023-12-31
- Completion
- 2023-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mesenchymal stem cells capable of differentiation in the endometrial-decidual direction | Cell therapy | — | — |